InvestorsHub Logo
Followers 22
Posts 4084
Boards Moderated 0
Alias Born 04/29/2016

Re: BlackDoggie post# 11180

Tuesday, 02/21/2017 3:59:18 PM

Tuesday, February 21, 2017 3:59:18 PM

Post# of 232309
GILD's Two Major Platforms are HCV, which is loosing traction, revenue and Profitability, and HIV, which is still somewhat intact. However, HIV is subject to patent expiration's in the next 12 to 18 months. PRO 140 could help fill that void.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News